TIGIT and PD-1 may serve as potential prognostic biomarkers for gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TIGIT and PD-1 may serve as potential prognostic biomarkers for gastric cancer

Published:2020-05 Issue:3 Volume:225 Page:151915
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Xu Danhua,Zhao Enhao,Zhu Chunchao,Zhao Wenyi,Wang Chaojie,Zhang Zizhen,Zhao Gang

Funder

National Natural Science Foundation of China

Projects of United Public Relations of Pudong New District

Projects of Shanghai Municipal Commission of Health and Family Planning

Projects of Science and Technology Commission of Shanghai Municipality

Projects of Shanghai Hospital Development Center

Cultivation Fund of Shanghai Ren Ji Hospital

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference34 articles.

1. TIGIT and PD-1 impair tumor antigen-specific CD8(+) T cells in melanoma patients;Chauvin;J. Clin. Invest.,2015

2. TIGIT marks exhausted t cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection;Chew;PLoS Pathog.,2016

3. Neoadjuvant chemotherapy: survival benefit in gastric cancer;Das;Lancet Oncol.,2017

4. Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT);Deuss;J. Biol. Chem.,2017

5. Lymphadenectomy in gastric cancer: contentious issues;Garg;World J. Gastrointest. Surg.,2016

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy;Frontiers in Immunology;2024-08-02

2. Structural and pharmacological insights into cordycepin for neoplasms and metabolic disorders;Frontiers in Pharmacology;2024-06-17

3. Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer;Frontiers in Oncology;2024-06-14

4. Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer;Clinica Chimica Acta;2024-05

5. CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy;Current Medicinal Chemistry;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3